DrugPatentWatch Database Preview
Sparc Company Profile
What is the competitive landscape for SPARC, and what generic alternatives to SPARC drugs are available?
SPARC has one approved drug.
There are five US patents protecting SPARC drugs.
There are twenty-three patent family members on SPARC drugs in eighteen countries and two supplementary protection certificates in two countries.
Summary for Sparc
| International Patents: | 23 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Sparc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sparc | ELEPSIA XR | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 204417-001 | Dec 20, 2018 | RX | Yes | No | 8,470,367 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Sparc | ELEPSIA XR | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 204417-002 | Dec 20, 2018 | RX | Yes | Yes | 8,535,717 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Sparc | ELEPSIA XR | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 204417-002 | Dec 20, 2018 | RX | Yes | Yes | 8,431,156 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Sparc | ELEPSIA XR | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 204417-002 | Dec 20, 2018 | RX | Yes | Yes | 8,163,306 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Sparc | ELEPSIA XR | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 204417-001 | Dec 20, 2018 | RX | Yes | No | 8,535,717 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Sparc | ELEPSIA XR | levetiracetam | TABLET, EXTENDED RELEASE;ORAL | 204417-001 | Dec 20, 2018 | RX | Yes | No | 8,425,938 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Sparc Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 1909770 | ➤ Sign Up |
| World Intellectual Property Organization (WIPO) | 2005039481 | ➤ Sign Up |
| Japan | 2015038126 | ➤ Sign Up |
| New Zealand | 546543 | ➤ Sign Up |
| Spain | 2403069 | ➤ Sign Up |
| South Korea | 101164881 | ➤ Sign Up |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for Sparc Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0162036 | C300028 | Netherlands | ➤ Sign Up | PRODUCT NAME: LEVETIRACETAM; REGISTRATION NO/DATE: EU/1/00/146/001 - EU/1/00/146/026 20000929 |
| 0162036 | 2000C/032 | Belgium | ➤ Sign Up | PRODUCT NAME: LEVETIRACETAM; NAT. REGISTRATION NO/DATE: EU/1/00/146/001 20000929; FIRST REGISTRATION: CH 55297 20000329 |
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
